» Articles » PMID: 11888900

Relation of Hypoxia-inducible Factor-2 Alpha (HIF-2 Alpha) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2002 Mar 13
PMID 11888900
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-associated macrophages (TAMs) produce angiogenic factors and in breast cancer are associated with high vascular grade and poor survival. TAMs preferentially migrate to hypoxic areas within tumors and strongly express hypoxia-inducible factor (HIF)-2 alpha. This study examined whether HIF-2 alpha was involved in TAM angiogenic activation by correlating its expression with tumor microvessel density as a marker of angiogenesis, and other tumor variables, in a series of human primary invasive breast carcinomas. A correlation was found between high TAM HIF-2 alpha and high tumor vascularity (P < 0.0001), as well as high tumor grade (P = 0.007). The relation of HIF-2 alpha expression to a recently described oxygen-dependent pathway of angiogenesis was also studied, and an inverse relationship was found between TAM HIF-2 alpha and tumor thymidine phosphorylase expression (P = 0.02). These results suggest that TAM HIF-2 signaling may be a useful target for future antiangiogenic strategies but show that tumors use both oxygen-dependent and oxygen deficiency-regulated pathways for angiogenesis. Thus, combined blockade of pathways and careful assessment of these pathways in trials are necessary.

Citing Articles

Subverting to Prevent : Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion.

Mastrogiovanni M, Donnadieu E, Pathak R, Di Bartolo V Biology (Basel). 2024; 13(11).

PMID: 39596815 PMC: 11591779. DOI: 10.3390/biology13110860.


Expression of HIF‑α and their association with clinicopathological parameters in clinical renal cell carcinoma.

Sitaram R, Ljungberg B Ups J Med Sci. 2024; 129.

PMID: 38571885 PMC: 10989218. DOI: 10.48101/ujms.v129.9407.


Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease.

Saad H, Baz A, Riad M, Eraky M, El-Taher A, Farid M BMC Immunol. 2024; 25(1):9.

PMID: 38273260 PMC: 10809557. DOI: 10.1186/s12865-023-00591-y.


Fasting mimicking diet inhibits tumor-associated macrophage survival and pro-tumor function in hypoxia: implications for combination therapy with anti-angiogenic agent.

Wang L, Wang Y, Wang R, Gong F, Shi Y, Li S J Transl Med. 2023; 21(1):754.

PMID: 37884960 PMC: 10601181. DOI: 10.1186/s12967-023-04577-7.


Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction.

Du J, Zhang C, Liu F, Liu X, Wang D, Zhao D J Mol Med (Berl). 2023; 101(10):1237-1253.

PMID: 37603049 DOI: 10.1007/s00109-023-02358-9.